Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study GroupUMEMURA, Shigeki; TSUBOUCHI, Kazuya; YAMANE, Hiromichi et al.Lung cancer. 2012, Vol 77, Num 1, pp 134-139, issn 0169-5002, 6 p.Article

Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Oncology Group StudyOKAMOTO, Isamu; YOSHIOKA, Hiroshige; KUDOH, Shinzoh et al.Journal of clinical oncology. 2010, Vol 28, Num 36, pp 5240-5246, issn 0732-183X, 7 p.Article

Efficacy and safety of erlotinib in elderly patients in the phase IV POLARSTAR surveillance study of Japanese patients with non-small-cell lung cancerYOSHIOKA, Hiroshige; KOMUTA, Kiyoshi; IMAMURA, Fumio et al.Lung cancer. 2014, Vol 86, Num 2, pp 201-206, issn 0169-5002, 6 p.Article

Association between poor performance status and risk for toxicity during erlotinib monotherapy in Japanese patients with non-small cell lung cancer: Okayama Lung Cancer Study Group experienceHOTTA, Katsuyuki; KIURA, Katsuyuki; TANIMOTO, Mitsune et al.Lung cancer. 2010, Vol 70, Num 3, pp 308-312, issn 0169-5002, 5 p.Article

Rebiopsy of Non―Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: Comparison Between T790M Mutation-Positive and Mutation-Negative PopulationsHATA, Akito; KATAKAMI, Nobuyuki; MATSUMOTO, Takeshi et al.Cancer. 2013, Vol 119, Num 24, pp 4325-4332, issn 0008-543X, 8 p.Article

Phase II Study of Combination Therapy with S-1 and Irinotecan for Advanced Non-Small Cell Lung Cancer : West Japan Thoracic Oncology Group 3505OKAMOTO, Isamu; NISHIMURA, Takashi; NAKAGAWA, Kazuhiko et al.Clinical cancer research (Print). 2008, Vol 14, Num 16, pp 5250-5254, issn 1078-0432, 5 p.Article

A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)GOTO, Koichi; NISHIO, Makoto; FUKUYAMA, Tamaki et al.Lung cancer. 2013, Vol 82, Num 1, pp 109-114, issn 0169-5002, 6 p.Article

Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selectionHATA, Akito; KATAKAMI, Nobuyuki; NISHIYAMA, Akihiro et al.Lung cancer. 2011, Vol 74, Num 2, pp 268-273, issn 0169-5002, 6 p.Article